Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1
Nico Janssen, Rémy Nyga, Lore Vanderbeke, Cato Jacobs, Mehmet Ergün, Jochem B. Buil, Karin van Dijk, Josje Altenburg, Catherine S. C. Bouman, Hans I. van der Spoel, Bart Rijnders, Albert Dunbar, Jeroen Schouten, Katrien Lagrou, Marc Bourgeois, Marijke Reynders, Niels Van Regenmortel, Lynn Rutsaert, Piet Lormans, Simon Feys, Yves Debavaye, Fabienne Tamion, Damien Costa, Julien Maizel, Hervé Dupont, Taïeb Chouaki, Saad Nseir, Boualem Sendid, Roger J. M. Brüggemann, Frank L. van de Veerdonk, Joost Wauters, Paul E. Verweij
Abstract
We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease-associated pulmonary aspergillosis (CAPA). We found 10%-15% CAPA incidence among 823 patients in 2 cohorts. Several factors were independently associated with CAPA in 1 cohort and mortality rates were 43%-52%.